HIV: reluctance to be tested means only 4,600 diagnosed Japanese cases

Published By Datamonitor

HIV/AIDS: number of treated patients in Japan will double by 2007

Published By Datamonitor

Prostate cancer: UK lowest for screening

Published By Datamonitor

HIV: Japanese HIV population to grow 15% per year

Published By Datamonitor

Medical devices: Japanese price cuts on the way

While prices of orthopedic devices in Japan are certainly higher than those in the US and Europe, the manufacturers claim that heavy costs make the high prices a necessity. The industry is eagerly awaiting the outcome of US/Japan trade negotiations - but if these fail to halt the cuts, orthopedic firms will certainly take a large hit.

Published By Datamonitor

Asthma: prevalence to increase worldwide

Published By Datamonitor

Anticonvulsants: 12% usage rate for US migraine prophylaxis

Published By Datamonitor

Asthma: UK top for diagnosis, US bottom

Published By Datamonitor

Tanabe: sun rising from the west

Tanabe hopes that teaming up with a foreign firm will help bolster its performance after five years of underachievement. Certainly, global partnership has recently proved to be a popular strategy for many other pharma companies in Japan. With few other prospects following the collapse of the Taisho merger, an international alliance may be the best move for Tanabe.

Published By Datamonitor

Lung cancer: non small cell most common in major markets

Published By Datamonitor